Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 3
1992 2
1994 3
1996 4
1997 4
1998 1
1999 2
2000 2
2001 4
2002 4
2003 2
2004 1
2005 2
2006 2
2008 1
2009 3
2010 1
2011 5
2012 4
2013 3
2014 2
2015 4
2016 2
2017 2
2018 1
2019 2
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

62 results
Results by year
Filters applied: . Clear all
Page 1
eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer.
Müller D, Shin S, Goullet de Rugy T, Samain R, Baer R, Strehaiano M, Masvidal-Sanz L, Guillermet-Guibert J, Jean C, Tsukumo Y, Sonenberg N, Marion F, Guilbaud N, Hoffmann JS, Larsson O, Bousquet C, Pyronnet S, Martineau Y. Müller D, et al. Among authors: guilbaud n. JCI Insight. 2019 Nov 1;4(21):e121951. doi: 10.1172/jci.insight.121951. JCI Insight. 2019. PMID: 31672935 Free PMC article.
Randomized, double-blind trial of F14512, a polyamine-vectorized anticancer drug, compared with etoposide phosphate, in dogs with naturally occurring lymphoma.
Boyé P, Floch F, Serres F, Segaoula Z, Hordeaux J, Pascal Q, Coste V, Courapied S, Bouchaert E, Rybicka A, Mazuy C, Marescaux L, Geeraert K, Fournel-Fleury C, Duhamel A, Machuron F, Ferré P, Pétain A, Guilbaud N, Tierny D, Gomes B. Boyé P, et al. Among authors: guilbaud n. Oncotarget. 2020 Feb 18;11(7):671-686. doi: 10.18632/oncotarget.27461. eCollection 2020 Feb 18. Oncotarget. 2020. PMID: 32133044 Free PMC article.
Actinic keratosis modelling in mice: A translational study.
Pillon A, Gomes B, Vandenberghe I, Cartron V, Cèbe P, Blanchet JC, Sibaud V, Guilbaud N, Audoly L, Lamant L, Kruczynski A. Pillon A, et al. Among authors: guilbaud n. PLoS One. 2017 Jun 29;12(6):e0179991. doi: 10.1371/journal.pone.0179991. eCollection 2017. PLoS One. 2017. PMID: 28662116 Free PMC article.
Acronycine derivatives as promising antitumor agents.
Guilbaud N, Léonce S, Tillequin F, Koch M, Hickman JA, Pierré A. Guilbaud N, et al. Anticancer Drugs. 2002 Jun;13(5):445-9. doi: 10.1097/00001813-200206000-00002. Anticancer Drugs. 2002. PMID: 12045455 Review.
Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer.
Leary A, Le Tourneau C, Varga A, Sablin MP, Gomez-Roca C, Guilbaud N, Petain A, Pavlyuk M, Delord JP. Leary A, et al. Among authors: guilbaud n. Invest New Drugs. 2019 Aug;37(4):693-701. doi: 10.1007/s10637-018-0688-4. Epub 2018 Dec 14. Invest New Drugs. 2019. PMID: 30547316 Free PMC article. Clinical Trial.
Triterpene saponins from Eryngium campestre.
Kartal M, Mitaine-Offer AC, Paululat T, Abu-Asaker M, Wagner H, Mirjolet JF, Guilbaud N, Lacaille-Dubois MA. Kartal M, et al. Among authors: guilbaud n. J Nat Prod. 2006 Jul;69(7):1105-8. doi: 10.1021/np060101w. J Nat Prod. 2006. PMID: 16872157
Melanoma chemotherapy leads to the selection of ABCB5-expressing cells.
Chartrain M, Riond J, Stennevin A, Vandenberghe I, Gomes B, Lamant L, Meyer N, Gairin JE, Guilbaud N, Annereau JP. Chartrain M, et al. Among authors: guilbaud n. PLoS One. 2012;7(5):e36762. doi: 10.1371/journal.pone.0036762. Epub 2012 May 24. PLoS One. 2012. PMID: 22675422 Free PMC article.
62 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page